class="MsoNormal">The National Pharmaceutical Pricing Authority (NPPA) on February 27, 2025, notified regarding the fixation of the retail price of Empagliflozin 5 mg + Metformin Hydrochloride IP 1000 mg (as extended release) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) and M/s Cadila Pharmaceuticals Ltd. (Marketer).
It has fixed the rate at Rs. 11.83/- for each film coated bilayered tablet containing: Empagliflozin 5 mg + Metformin Hydrochloride IP 1000 mg (as extended release) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) and M/s Cadila Pharmaceuticals Ltd. (Marketer).
